RC: 640303
NOTORE CHEMICAL INDUSTRIES PLC UNAUDITED INTERIM FINANCIAL STATEMENTS
FOR THE TWELVE MONTHS PERIOD ENDED 31 DECEMBER 2022
NOTORE CHEMICAL INDUSTRIES PLC
UNAUDITED INTERIM FINANCIAL STATEMENTS
FOR THE TWELVE MONTHS PERIOD ENDED 31 DECEMBER 2022
Page | |
Financial statements | |
Consolidated and separate statements of financial position | 1 |
Consolidated and separate statements of profit or loss and other comprehensive income | 2 |
Consolidated and separate statements of profit or loss and other comprehensive income(Three months) | 3 |
Consolidated and separate statements of cash flows | 4 |
Consolidated and separate statements of changes in equity | 5 |
Notes to the financial statements | 7 |
NOTORE CHEMICAL INDUSTRIES PLC
UNAUDITED CONSOLIDATED AND SEPARATE STATEMENTS OF FINANCIAL POSITION
AS AT 31 DECEMBER 2022
(All amounts are in thousands of Naira, unless otherwise stated)
Group | Company |
Notes
31 Dec 2022
31 Dec 2021
31 Dec 2022
31 Dec 2021
N'000 | N'000 | N'000 | N'000 | ||
Non-current assets | |||||
Property, plant and equipment | 14 | 179,592,887 | 151,293,681 | 179,592,885 | 151,293,678 |
Right of use assets | 15 | 209,658 | 30,429 | 209,658 | 30,429 |
Investment property | 16 | 74,867,378 | 68,339,210 | 74,867,378 | 68,339,210 |
Investments in subsidiaries | 27 | - | - | 50,255 | 50,255 |
Total non-current assets | 254,669,923 | 219,663,320 | 254,720,176 | 219,713,572 | |
Current assets | |||||
Inventories | 18 | 9,386,559 | 9,323,397 | 9,342,035 | 9,289,549 |
Trade and other receivables | 19a | 1,752,076 | 3,928,063 | 2,343,533 | 4,366,929 |
EEG Receivable | 19b | 4,540,129 | 4,540,129 | 4,540,129 | 4,540,129 |
Cash at bank and in hand | 20 | 570,161 | 1,164,890 | 462,672 | 1,029,885 |
Total current assets | 16,248,925 | 18,956,479 | 16,688,369 | 19,226,492 | |
Total assets | 270,918,848 | 238,619,799 | 271,408,545 | 238,940,064 | |
Equity | |||||
Ordinary shares | 21 | 806,033 | 806,033 | 806,033 | 806,033 |
Share premium | 27,995,916 | 27,995,916 | 27,995,916 | 27,995,916 | |
Asset revaluation reserves | 83,237,274 | 60,124,144 | 83,237,274 | 60,124,144 | |
Accumulated losses | 22 | (51,045,284) | (34,816,713) | (50,742,515) | (34,406,142) |
Treasury shares reserve | (1,080,831) | (1,080,831) | (1,080,831) | (1,080,831) | |
Total equity | 59,913,108 | 53,028,549 | 60,215,877 | 53,439,120 | |
Liabilities | |||||
Non-current liabilities | |||||
Borrowings | 24a | 109,760,326 | 79,962,615 | 109,760,326 | 79,962,615 |
Employee benefit obligation | 23 | 1,851,236 | 1,850,646 | 1,851,236 | 1,850,646 |
Grant liability | 24b | 1,691,539 | 2,625,073 | 1,691,539 | 2,625,073 |
Deferred tax liability | 12a | 9,905,627 | - | 9,905,627 | - |
Total non-current liabilities | 123,208,728 | 84,438,334 | 123,208,728 | 84,438,334 | |
Current liabilities | |||||
Borrowings | 24a | 30,848,474 | 49,076,352 | 30,848,474 | 49,076,352 |
Lease liability | 15(b) | 187,731 | - | 187,731 | - |
Trade and other payables | 25 | 55,693,082 | 50,843,613 | 55,880,010 | 50,753,307 |
Grant liability | 24b | 1,043,763 | 1,167,241 | 1,043,763 | 1,167,241 |
Current tax liabilities | 12 | 23,962 | 65,710 | 23,962 | 65,710 |
Total current liabilities | 87,797,012 | 101,152,916 | 87,983,940 | 101,062,610 | |
Total liabilities | 211,005,740 | 185,591,250 | 211,192,668 | 185,500,944 | |
Total equity and liabilities | 270,918,848 | 238,619,799 | 271,408,545 | 238,940,064 | |
The financial statements on pages were approved and authorised for issue by the board of directors on 27th January 2023 and signed on its behalf by:
Mr. Ohis Ohiwerei | Mr. Onajite P. Okoloko | Ms. Chekwubechukwu Onianwa | ||
Managing Director/CEO | Director | Chief Financial Officer | ||
FRC/2017/CIBN/00000016412 | FRC/2014/NIM/00000007662 | FRC/2022/PRO/ICAN/001/704370 |
The notes on pages 7 to 32 are an integral part of these financial statements.
1
NOTORE CHEMICAL INDUSTRIES PLC
UNAUDITED CONSOLIDATED AND SEPARATE STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME FOR THE TWELVE MONTHS PERIOD ENDED 31 DECEMBER 2022
(All amounts are in thousands of Naira, unless otherwise stated)
Group | Company |
Notes
Twelve months | Fifteen months | Twelve months | Fifteen months |
31 Dec 2022 | 31 Dec 2021 | 31 Dec 2022 | 31 Dec 2021 |
N'000 | N'000 | N'000 | N'000 |
Revenue from contracts with customers | 7 | 33,198,809 | 25,706,264 | 32,226,698 | 25,484,427 |
Cost of sales | 8 | (26,492,146) | (28,975,786) | (26,019,102) | (28,783,081) |
GrossProfit/(loss) | 6,706,663 | (3,269,522) | 6,207,596 | (3,298,654) | |
Administrative expenses | 9 | (6,901,867) | (6,896,702) | (6,526,418) | (6,451,252) |
Selling and distribution expenses | 9b | (189,678) | (272,047) | (173,862) | (266,707) |
Other income | 10 | 7,585,725 | 17,126,229 | 7,585,725 | 17,206,631 |
Operating income/(loss) | 7,200,843 | 6,687,958 | 7,093,041 | 7,190,018 | |
Finance income | 11a | 151 | 388 | 151 | 388 |
Finance cost | 11b | (23,429,565) | (26,427,010) | (23,429,565) | (26,427,010) |
Finance costs - (net) | 11 | (23,429,414) | (26,426,622) | (23,429,414) | (26,426,622) |
Loss before income tax | (16,228,571) | (19,738,664) | (16,336,373) | (19,236,604) | |
Income tax | 12 | - | 10,162,622 | - | 10,162,622 |
Loss for the period | (16,228,571) | (9,576,042) | (16,336,373) | (9,073,982) | |
Other comprehensive income: | |||||
Items that will not be reclassified to profit or loss | |||||
Remeasurement of employee benefit obligations | 25a | - | 67,628 | - | 67,628 |
Deferred tax credit/(charge) on actuarial loss/gain | 12a | - | (20,288) | - | (20,288) |
Revaluation surplus on property, plant and equipment | 14 | 33,018,757 | - | 33,018,757 | - |
Deferred tax charge on revaluation surplus | 12a | (9,905,627) | - | (9,905,627) | - |
Total items that will not be reclassified to profit or loss | 23,113,130 | 47,340 | 23,113,130 | 47,340 | |
Items that may be subsequently reclassified to profit or loss | |||||
Currency translation difference | - | - | - | - | |
Total items that may be reclassified to profit or loss | - | - | - | - | |
Other comprehensive income for the period- | |||||
net of tax | 23,113,130 | 47,340 | 23,113,130 | 47,340 | |
Total comprehensive profit/(loss) for the period | 6,884,559 | (9,528,703) | 6,776,757 | (9,026,643) | |
Total comprehensive profit/(loss) for the period attributable to: | |||||
Equity holders of the parent company | 6,884,559 | (9,528,703) | 6,776,757 | (9,026,643) | |
Non controlling interest | - | - | - | - | |
Earnings per share for loss attributable to the equity | |||||
holders of the company | |||||
Basic EPS (Naira) | 13 | (10.07) | (5.94) | (10.13) | (5.63) |
The notes on pages 7 to 32 are an integral part of these financial statements.
2
NOTORE CHEMICAL INDUSTRIES PLC
UNAUDITED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
FOR THE THREE MONTHS PERIOD ENDED 31 DECEMBER 2022
(All amounts are in thousands of Naira, unless otherwise stated) | |||||
Group | Company | ||||
Three months | Three months | Three months | Three months | ||
Note | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2022 | 31 Dec 2021 | |
N'000 | N'000 | N'000 | N'000 | ||
Revenue from contracts with customers | 29 | 250,736 | 8,239,563 | 50,280 | 9,205,116 |
Cost of sales | 30 | (3,403,745) | (7,447,695) | (3,309,415) | (7,447,695) |
Gross profit | (3,153,009) | 791,868 | (3,259,135) | 1,757,421 | |
Administrative expenses | 31a | (1,723,477) | (505,608) | (1,654,057) | (404,728) |
Selling and distribution expenses | 31b | (27,674) | (53,254) | (27,174) | (52,415) |
Other income | 32 | 48,709 | 9,431,787 | 48,709 | 8,957,883 |
Operating income | (4,855,452) | 9,664,792 | (4,891,658) | 10,258,160 | |
Finance income | 33 | 50 | - | 50 | - |
Finance cost | 33b | (10,423,574) | (9,728,137) | (10,423,574) | (9,728,137) |
Finance costs - (net) | 33 | (10,423,524) | (9,728,137) | (10,423,524) | (9,728,137) |
Profit/(loss) before income tax | (15,278,976) | (63,346) | (15,315,183) | 530,022 | |
Income tax | - | 10,162,622 | - | 10,162,622 | |
Profit/(loss) for the period | (15,278,976) | 10,099,276 | (15,315,183) | 10,692,644 | |
Other comprehensive income: | |||||
Items that will not be reclassified to profit or loss | |||||
Remeasurement of employee benefit obligations | - | 67,628 | - | 67,628 | |
Deferred tax credit/(charge) on actuarial loss/gain | - | (20,288) | - | (20,288) | |
Revaluation surplus on property, plant and equipment | 33,018,757.37 | - | 33,018,757 | - | |
Deferred tax charge on revaluation surplus | (9,905,627.21) | - | (9,905,627) | - | |
Total items that will not be reclassified to profit or loss | 23,113,130 | 47,340 | 23,113,130 | 47,340 | |
Items that may be subsequently reclassified to profit or loss | |||||
Currency translation difference | - | (44,672) | - | - | |
Total items that may be reclassified to profit or loss | - | (44,672) | - | - | |
Other comprehensive income for the period- | |||||
net of tax | 23,113,130 | 2,668 | 23,113,130 | 47,340 | |
Total comprehensive profit / (loss) for the period | 7,834,155 | 10,101,944 | 7,797,947 | 10,739,984 | |
Total comprehensive profit /(loss) for the year attributable to: | |||||
Equity holders of the parent company | 7,834,155 | 10,101,944 | 7,797,947 | 10,739,984 | |
Non controlling interest | - | - | - | - | |
Earnings per share for loss attributable to the equity | |||||
holders of the company | |||||
Basic EPS (Naira) | (9.48) | 6.26 | (9.50) | 6.63 | |
3
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Notore Chemical Industries plc published this content on 30 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 January 2023 10:23:12 UTC.